Concurrent treatment of obstructive sleep apnea and hypertension in a patient, via a pressure generating system, includes providing a flow of treatment gas to an airway of a patient in accordance with an initial set of flow parameters with respect to an obstructive sleep apnea mode. Responsive to determining that the patient has achieved stable breathing while receiving the flow of treatment gas, the flow parameters are increased above the initial set of flow parameters with respect to a hyper-ventilation mode. The flow of treatment gas is then provided to the airway of the patient in accordance with the increased flow parameters for a predetermined period of time. The increased flow parameters are configured to bring the patient's breath into accordance with target patient breath parameters configured to inflate the patient's lungs beyond a threshold for activating pulmonary stretch receptors of the airway of the patient.

Concurrent treatment of obstructive sleep apnea and hypertension in a patient, via a pressure generating device, includes providing a flow of treatment gas to an airway of a patient in accordance with an initial set of flow parameters with respect to an obstructive sleep apnea mode. Responsive to determining that the patient has achieved stable breathing while receiving the flow of treatment gas, the flow parameters are increased above the initial set of flow parameters with respect to a hyper-ventilation mode. The flow of treatment gas is then provided to the airway of the patient in accordance with the increased flow parameters for a predetermined period of time. The increased flow parameters are configured to bring the patient's breath into accordance with target patient breath parameters configured to inflate the patient's lungs beyond a threshold for activating pulmonary stretch receptors of the airway of the patient.

The present invention relates to an electrically operable resuscitation device comprising a piston/cylinder assembly including a rigid cylinder including at least one gas inlet and at least one gas outlet, a piston to travel in said cylinder, and at least one valve, the or each valve configured to allow gas to be displaced into said cylinder through said at least one gas inlet during at least one of a first stroke direction and second stroke direction of said piston in said cylinder, and for allowing gas to displaced through said at least one gas outlet during an opposite of said at least one of the first stroke direction and second stroke direction of said piston in said cylinder; a motor, selected from one of a stepper motor and feedback motor and stepper motor with feedback and linear motor, operatively connected to said piston to move said piston in said cylinder; a patient interface in ducted fluid connection with said piston/cylinder assembly to receive gas via said at least one gas outlet and to deliver said gas to said patient.

A check valve can include a pressure actuator or an electromagnetic actuator. The check valve includes a valve inlet, a valve outlet, and flap disposed between the valve inlet and the valve outlet. The pressure actuator in fluid communication with the valve inlet. The check valve has an open state and a closed state. The check valve is configured to allow an input gas to flow from the valve inlet to the valve outlet when the check valve is in the open state. The check valve is configured to preclude the input gas from flowing from the valve inlet to the valve outlet when the check valve is in the closed state. Upon actuation of the pressure actuator or the electromagnetic actuator, the flap moves away from the valve inlet to allow the inlet gas to move from the valve inlet to the valve outlet.

The present disclosure relates to methods for treating a respiratory system of a subject, as well as medicine delivery devices for delivering an aerosol medicine to a subject in need thereof. A benefit to the methods herein can be generating a respiratory pattern of a subject that can accurately measure inhalation and exhalation patterns, which can in turn provide a benefit of more efficient and timely delivery of an aerosol medicine to a subject in need thereof. Additional benefits to the methods and devices herein can be helping to improve treatment outcomes, as well as avoiding wastage of expensive medicines. Additional benefits to the medicine delivery devices disclosed herein can be non-invasive, low cost, lightweight, compact, versatile, and simple to use devices useful for a wide range of patients and healthcare settings. Another benefit of the medicine delivery devices can be providing a single-use device that can lower the risk of infection for patients and healthcare providers.

A breathable gas inlet control device permits flow regulation at the inlet of a flow generator for a respiratory treatment apparatus such as a ventilator or continuous positive airway pressure device. The device may implement a variable inlet aperture size based on flow conditions. In one embodiment, an inlet flow seal opens or closes the inlet to a blower in accordance with changes in pressure within a seal activation chamber near the seal. The seal may be formed by a flexible membrane. A controller selectively changes the pressure of the seal activation chamber by controlling a set of one or more flow control valves to selectively stop forward flow, prevent back flow or lock open the seal to permit either back flow or forward flow. The controller may set the flow control valves as a function of detected respiratory conditions based on data from pressure and/or flow sensors.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

Respiratory systems with a flow generator can provide bubble CPAP therapy by controlling the pressure of a flow of gas delivered to a patient. The controller of the respiratory system can control a motor speed of its flow generator so as to control the pressure of the flow of gas. The controller can also detect presence of bubbling and/or possible leaks in the gas pathway of the system. The respiratory system can include a high flow respiratory system.

Disclosed is a respirator which comprises an electronic control device and a pneumatic main line in which the following are connected pneumatically: a respiratory gas source, a valve, a mixing chamber, a gas-dosing unit, and a supply line. The gas-dosing unit is configured to convey external air and/or oxygen and/or anesthetic gas into the mixing chamber, the respiratory gas source is configured to deliver respiratory gas to the supply line, the mixing chamber is configured to make available respiratory gas, the supply line is configured to supply the patient with respiratory gas, and the valve is configured to at least temporarily reduce a stream of respiratory gas to a patient.

An aspect of the present invention is a consciousness disorder mitigation apparatus, including: a first estimation unit configured to estimate body fluid volume information, the body fluid volume information being information on a body fluid volume present in a head of a user; a second estimation unit configured to estimate oxygen supply volume information, the oxygen supply volume information being information on an oxygen supply volume representing an amount of oxygen in a brain of the user; a pressurization unit configured to be attached to the user and to apply a pressure corresponding to an estimation result of the first estimation unit and an estimation result of the second estimation unit; and an oxygen supply unit configured to supply oxygen to the user based on the estimation result of the second estimation unit.